Current NDC auxiliary source row compounder:866

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 83298-517
Product Ndc: 83298-517
Product Ndc Digits: 83298517
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Oxytocin
Proprietary Name Suffix: [empty]
Nonproprietary Name: Oxytocin Injection
Dosage Form Name: INJECTION
Route Name: INTRAMUSCULAR; INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Mark Cuban Cost Plus Manufacturing and Compounding LLC
Establishment Name: Mark Cuban Cost Plus Manufacturing and Compounding LLC
Establishment Fei: [empty]
Substance Name: OXYTOCIN
Active Ingredients Info: 10 [USP'U]/1 mL
History Active Ingredients Raw: OXYTOCIN
History Active Ingredients Info Raw: 10 [USP'U]/1 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 83298-517-10
Package Ndc: 83298-517-10
Package Ndc Digits: 8329851710
Package Ndc11: 83298051710
Package Description: 10 VIAL in 1 CARTON (83298-517-10) > 3 mL in 1 VIAL (83298-517-05)
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:866
Source Row Number: 866
Source Row Hash: 75f2f9d807479a2ca0884289f8cfa4e178f2dda3760b23325af03c987ef4f0a7
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR; INTRAVENOUS",
    "PRODUCTNDC": "83298-517",
    "DEASCHEDULE": "",
    "LABELERNAME": "Mark Cuban Cost Plus Manufacturing and Compounding LLC",
    "SUBSTANCENAME": "OXYTOCIN",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "83298-517-10",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Oxytocin",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Oxytocin Injection",
    "PACKAGEDESCRIPTION": "10 VIAL in 1 CARTON (83298-517-10)  > 3 mL in 1 VIAL (83298-517-05) ",
    "ACTIVEINGREDIENTSINFO": "10 [USP'U]/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:866
Source Row Number: 866
Status Scope: package
Lookup Ndc: 83298-517-10
Lookup Ndc Digits: 8329851710
Product Ndc: 83298-517
Product Ndc Digits: 83298517
Package Ndc: 83298-517-10
Package Ndc Digits: 8329851710
Package Ndc11: 83298051710
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 75f2f9d807479a2ca0884289f8cfa4e178f2dda3760b23325af03c987ef4f0a7
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51